NCT03478202View on ClinicalTrials.gov

GOLO Open-Label Pilot 1

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

December 23, 2017

Study Completion Date

December 23, 2017

Conditions
Diabetes Mellitus, Type II
Interventions
DIETARY_SUPPLEMENT

GOLO RELEASE

GOLO RELEASE plus Diet

Trial Locations (1)

46385

Buynak Clinical Research, Valparaiso

All Listed Sponsors
lead

Golo

INDUSTRY

NCT03478202 - GOLO Open-Label Pilot 1 | Biotech Hunter | Biotech Hunter